3
20. 5. 2015.
Therapeutic biomarker differences between MSI-H and MSS colorectal cancers.
3597 Background: Approximately 15% of colorectal cancers (CRC) display high level of microsatellite instability (MSI-H) due to either hereditary predisposition (Lynch syndrome, LS) or somatic hyper...